GHK-Cu Quick Start
GHK-Cu is a copper-binding tripeptide (glycyl-L-histidyl-L-lysine bound to copper(II)). The GHK sequence occurs naturally in human plasma and declines with age. It is studied for skin remodeling, collagen synthesis, wound healing, hair-follicle support, and anti-inflammatory/antioxidant activity, most often in cell-culture and animal models, plus topical cosmetic research.
This guide is an educational research reference. It does not diagnose, treat, or prescribe, and is not medical advice. Consult a licensed clinician before considering any compound.
GHK-Cu Dosing Protocols
The injectable (subcutaneous) and nasal-spray formats are documented as two separate protocols. Ranges below are research-planning references drawn from community-derived protocols and preclinical literature, not personal dosing recommendations. GHK-Cu is also widely studied as a topical cosmetic ingredient, which is a separate context from the injectable research ranges shown here.
Injection — Subcutaneous
| Band | Per dose | Frequency |
|---|---|---|
| Low | 1 mg | Once daily |
| Standard | 2 mg | Once daily |
Nasal Spray
| Band | Per dose | # of sprays | Frequency |
|---|---|---|---|
| Low | 1 mg | 1 spray | Once daily |
| Standard | 2 mg | 2 sprays | Once daily |
Cycle guidelines
| Approach | Duration | Review point | Best for |
|---|---|---|---|
| Standard | 4–6 weeks | Week 4 | General research planning |
| Extended | 6–8 weeks | Week 6 | Skin/tissue-remodeling models |
Off periods of 2–4 weeks between cycles are common in research planning, partly to limit cumulative copper exposure. There is no published human cycling RCT.
GHK-Cu Reconstitution Guide
GHK-Cu ships as a lyophilized powder (often a deep blue color from the bound copper). The bacteriostatic (BAC) water volume sets the concentration and draw volume for the injectable vial. Nasal sprays ship pre-mixed and ready to use.
Injection
| BAC | Conc. | 1 mg |
|---|---|---|
| 2 mL | 50 mg/mL | 0.02 mL · 2 u |
| 3 mL | 33.3 mg/mL | 0.03 mL · 3 u |
The vial holds up to 3 mL; 2 mL is the default. Units are U-100 syringe units.
Reconstitution steps
- Inspect the vial. Confirm the label and that the powder is intact. GHK-Cu is normally blue.
- Wipe the stoppers. Alcohol swab on both the BAC water and peptide vial stoppers.
- Draw BAC water. 2–3 mL into the vial for injection (vial max ~3 mL).
- Inject down the wall. Release water slowly down the inside wall, not onto the powder.
- Swirl, do not shake. Roll gently until fully dissolved and clear blue.
- Verify. Solution should be clear (blue tint expected). Discard if cloudy or particulate.
- Refrigerate. Store at 2–8 °C; do not freeze the reconstituted solution.
How to use the nasal spray
- Prime first use. Pump 2–3 sprays into a tissue until a fine, even mist appears.
- Position. Tilt the head slightly forward; insert the tip just inside one nostril, aimed slightly outward toward the ear — not at the septum.
- Spray and breathe. Press once while breathing in gently; do not sniff hard, which sends the solution down the throat instead of onto the mucosa.
- Alternate nostrils. For multi-spray doses, switch nostrils each spray to spread absorption and limit irritation.
- Count per the protocol. Use the sprays-per-dose shown above; if a dose isn't a whole number, round up.
- Between uses. Wipe the tip, recap, and refrigerate.
How GHK-Cu Works
GHK-Cu is a copper carrier. By delivering copper(II) to cells and modulating gene expression, it has been reported in cell and animal models to stimulate collagen, elastin, and glycosaminoglycan synthesis, support fibroblast activity, and promote angiogenesis in wound settings. Large-scale gene-expression work has reported GHK influencing thousands of human genes, including pathways linked to tissue remodeling and antioxidant defense.
Matrix synthesis
Reported to upregulate collagen and elastin production in skin-model research.
Copper transport
Delivers copper, a cofactor for enzymes involved in tissue repair and antioxidant defense.
Anti-inflammatory
Animal/cell data report reduced inflammatory signaling and oxidative stress.
Open question
Most robust human data is topical/cosmetic; systemic injectable outcomes are not established in trials.
Who Should Avoid GHK-Cu
Copper-metabolism disorders
Wilson's disease or other copper-handling conditions — GHK-Cu adds copper and should be avoided.
Active or prior cancer
Angiogenesis is part of the mechanism; discuss with a clinician given theoretical concerns.
Pregnancy & lactation
No human reproductive safety data for injectable use.
High cumulative dosing
Prolonged high doses raise the theoretical risk of copper accumulation.
GHK-Cu Side Effects & Safety
Injection-site reactions
Redness, stinging, or small bumps are the most commonly reported short-term issues; rotate sites.
Copper load
Theoretical risk with high or prolonged dosing; cycling and off-periods are common precautions.
Topical tolerance
In cosmetic use, GHK-Cu is generally well tolerated; mild irritation is occasionally reported.
Quality-control risk
Verify identity and purity against a Certificate of Analysis; grey-market material varies.
Timeline & What to Monitor
| Timeframe | Commonly tracked | Notes |
|---|---|---|
| Weeks 1–2 | Injection-site tolerance | Skin-quality endpoints are slow; early changes are tolerability, not remodeling. |
| Weeks 4–6 | Skin/appearance self-report (cosmetic context) | Most cosmetic studies assess over weeks. |
| Cumulative | Copper exposure over repeated cycles | Off-periods limit accumulation; no peptide-specific lab standard exists. |
Research Evidence Context
Cosmetic / topical
The strongest human data is topical: small studies report improvements in skin appearance and collagen markers.
Preclinical repair
Animal and cell models report wound-healing, angiogenesis, and matrix-synthesis effects.
Gene expression
GHK has been reported to modulate a large number of human genes in expression studies.
Open question
No large human RCT supports systemic injectable GHK-Cu for any indication.
Storage & Handling
| State | Storage | Notes |
|---|---|---|
| Lyophilized (powder) | −20 °C long-term; fridge short-term | Blue powder; more stable than reconstituted solution. |
| Reconstituted (liquid) | 2–8 °C | Use within ~3–4 weeks; do not freeze. |
| Appearance | Clear blue solution | Discard cloudy or particulate solutions. |
Mistakes & Troubleshooting
- Cloudy or off-color solution. A clear blue tint is normal; cloudiness or particulate means discard.
- Draws too small to read. Use the 3 mL (33 mg/mL) reconstitution for slightly larger draws — the vial holds up to ~3 mL.
- Missed dose. Skip and continue at the next scheduled time; do not double-dose.
- Persistent injection-site reaction. Rotate sites; use a fresh syringe and swab each session.
- Left out overnight. Treat reconstituted solution as compromised and discard.
GHK-Cu in Context
| Feature | GHK-Cu | BPC-157 / TB-500 |
|---|---|---|
| Class | Copper tripeptide | Synthetic repair peptides |
| Research focus | Skin, collagen, cosmetic remodeling | Tendon, gut, vessel, soft-tissue |
| Combined | GHK-Cu is the dominant component of the GLOW blend (with BPC-157 + TB-500). | |
Blood Tests & Monitoring
No peptide-specific lab exists for GHK-Cu. Where prolonged or high-dose research is planned, general markers may be discussed with a clinician.
| Marker | Why | Timing |
|---|---|---|
| Serum copper / ceruloplasmin | Context for cumulative copper exposure | Baseline / as advised |
| CBC, CMP | General safety screen | Baseline |
Frequently Asked Questions
What is GHK-Cu?
A naturally occurring copper-binding tripeptide (glycyl-histidyl-lysine + copper) studied for skin remodeling, collagen synthesis, and wound repair.
How is the injection dosed vs the nasal spray?
Separate protocols. Injection commonly references 1–2 mg once daily SubQ. The spray (100 mg in 10 mL) delivers 1 mg per spray, so 1–2 sprays once daily matches the 1–2 mg range.
How is GHK-Cu reconstituted?
For injection, 100 mg in 2 mL BAC water gives 50 mg/mL, so 1 mg = 0.02 mL = 2 units (the vial holds up to ~3 mL). The spray ships pre-mixed and delivers 1 mg per spray. The powder and solution are normally blue.
Is GHK-Cu the same as topical copper peptide creams?
It's the same molecule used in some topical cosmetics, but topical and injectable are different contexts. Topical cosmetic use has the most human data; injectable research ranges are community-derived.
Is this page medical advice?
No. It is an educational research reference and does not diagnose, treat, or prescribe. Consult a licensed clinician before considering any compound.
References
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide. Int J Mol Sci (2018).
- Pickart L, et al. The human tripeptide GHK and tissue remodeling. J Biomater Sci Polym Ed (2008).
- Pickart L, et al. GHK peptide as a natural modulator of multiple cellular pathways. Biomed Res Int (2015).
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK and DNA: resetting the human genome to health. Biomed Res Int (2014).
- Badenhorst T, et al. Pharmacokinetics of copper peptide formulations. Pharmaceutics (review).